The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Molecular Cloning of the CA125 Ovarian Cancer Antigen
Open accessAbstract
CA125 is an ovarian cancer antigen that is the basis for a widely used serum assay for the monitoring of patients with ovarian cancer; however, detailed information on its biochemical and molecular nature is lacking. We now report the isolation of a long, but partial, cDNA that corresponds to the CA125 antigen. A rabbit polyclonal antibody produced to purified CA125 antigen was used to screen a lambdaZAP cDNA library from OVCAR-3 cells in Escherichia coli. The longest insert from the 54 positive isolated clones had a 5797-base pair sequence containing a stop codon and a poly(A) sequence but no clear 5' initiation sequence. The deduced amino acid sequence has many of the attributes of a mucin molecule and was designated CA125/MUC16 (gene MUC16). These features include a high serine, threonine, and proline content in an N-terminal region of nine partially conserved tandem repeats (156 amino acids each) and a C-terminal region non-tandem repeat sequence containing a possible transmembrane region and a potential tyrosine phosphorylation site. Northern blotting showed that the level of MUC16 mRNA correlated with the expression of CA125 in a panel of cell lines. The molecular cloning of the CA125 antigen will lead to a better understanding of its role in ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
Bast, R. C., Klug, T. L., John, E. S., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310133091503 · Cited by 2,135
Reactivity of a monoclonal antibody with human ovarian carcinoma.
Bast, R. C., Feeney, M., Lazarus, H., Nadler, L. M., Colvin, R. B., & Knapp, R. C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110380 · Cited by 1,661
Gendler, S. J., & Spicer, A. P. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003135 · Cited by 979
The Structure and Assembly of Secreted Mucins
Perez-Vilar, J., & Hill, R. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31751 · Cited by 531
Cooper, J. A., Esch, F. S., Taylor, S. S., & Hunter, T. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42869-9 · Cited by 401
CA 125: The past and the Future
Bast, R. C., Xu, F.-J., Yu, Y.-H., Barnhill, S., Zhang, Z., & Mills, G. B. (1998) · The International Journal of Biological Markers · doi:10.1177/172460089801300402 · Cited by 397
Human gastric mucin. Identification of a unique species by expression cloning.
Toribara, N. W., Roberton, A. M., Ho, S. B., Kuo, W. L., Gum, E., Hicks, J. W., Gum, J. R., Byrd, J. C., Siddiki, B., & Kim, Y. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53402-5 · Cited by 365
MUC13, a Novel Human Cell Surface Mucin Expressed by Epithelial and Hemopoietic Cells
Williams, S. J., Wreschner, D. H., Tran, M., Eyre, H. J., Sutherland, G. R., & McGuckin, M. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008850200 · Cited by 327
Analysis of the sequence of amino acids surrounding sites of tyrosine phosphorylation.
Patschinsky, T., Hunter, T., Esch, F. S., Cooper, J. A., & Sefton, B. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.4.973 · Cited by 313
(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1174 · Cited by 276
Cited by
TFOS DEWS II pathophysiology report
Bron, A. J., de Paiva, C. S., Chauhan, S. K., Bonini, S., Gabison, E. E., Jain, S., Knop, E., Markoulli, M., Ogawa, Y., Perez, V., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.011 · Cited by 1,815
Mucins in cancer: protection and control of the cell surface
Hollingsworth, M. A., & Swanson, B. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1251 · Cited by 1,807
The gastrointestinal mucus system in health and disease
Johansson, M. E. V., Sjövall, H., & Hansson, G. C. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.35 · Cited by 1,438
Mucins in cancer: function, prognosis and therapy
Kufe, D. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2761 · Cited by 1,396
Pelaseyed, T., Bergström, J. H., Gustafsson, J. K., Ermund, A., Birchenough, G. M. H., Schütte, A., van der Post, S., Svensson, F., Rodríguez‐Piñeiro, A. M., Nyström, E. E. L., et al. (2014) · Immunological Reviews · doi:10.1111/imr.12182 · Cited by 1,363
The biology of ovarian cancer: new opportunities for translation
Bast, R. C., Hennessy, B., & Mills, G. B. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2644 · Cited by 1,358
Mucins in the mucosal barrier to infection
Linden, S. K., Sutton, P., Karlsson, N. G., Korolik, V, & McGuckin, M. A. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.5 · Cited by 1,234
Sturgeon, C. M., Duffy, M. J., Stenman, U.-H., Lilja, H., Brünner, N., Chan, D. W., Babaian, R., Bast, R. C., Dowell, B., Esteva, F. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105601 · Cited by 1,129
Respiratory Tract Mucin Genes and Mucin Glycoproteins in Health and Disease
Rose, M. C., & Voynow, J. A. (2006) · Physiological Reviews · doi:10.1152/physrev.00010.2005 · Cited by 1,066
Sialic acids in human health and disease
Varki, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.06.002 · Cited by 999
Protein Glycosylation in Cancer
Stowell, S. R., Ju, T., & Cummings, R. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040438 · Cited by 873
Trousseau's syndrome: multiple definitions and multiple mechanisms
Varki, A. (2007) · Blood · doi:10.1182/blood-2006-10-053736 · Cited by 840
Structure and Function of the Cell Surface (Tethered) Mucins
Hattrup, C. L., & Gendler, S. J. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100659 · Cited by 779
Jackson, H. J., Rafiq, S., & Brentjens, R. J. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.36 · Cited by 613
CA125 and Ovarian Cancer: A Comprehensive Review
Charkhchi, P., Cybulski, C., Gronwald, J., Wong, F. O., Narod, S. A., & Akbari, M. R. (2020) · Cancers · doi:10.3390/cancers12123730 · Cited by 602
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion
Rump, A., Morikawa, Y., Tanaka, M., Minami, S., Umesaki, N., Takeuchi, M., & Miyajima, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312372200 · Cited by 572
Physicochemical properties of mucus and their impact on transmucosal drug delivery
Leal, J., Smyth, H. D. C., & Ghosh, D. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.018 · Cited by 560
Mucin-bacterial interactions in the human oral cavity and digestive tract
Derrien, M., van Passel, M. W. J., van de Bovenkamp, J. H. B., Schipper, R., de Vos, W., & Dekker, J. (2010) · Gut Microbes · doi:10.4161/gmic.1.4.12778 · Cited by 556
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
Felder, M., Kapur, A., Gonzalez-Bosquet, J., Horibata, S., Heintz, J., Albrecht, R., Fass, L., Kaur, J., Hu, K., Shojaei, H., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-129 · Cited by 524
New tumor markers: CA125 and beyond
BAST, R. C., BADGWELL, D., LU, Z., MARQUEZ, R., ROSEN, D., LIU, J., BAGGERLY, K. A., ATKINSON, E. N., SKATES, S., ZHANG, Z., et al. (2005) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2005.00441.x · Cited by 504
Mucins and mucin binding proteins in colorectal cancer
Byrd, J. C., & Bresalier, R. S. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025815113599 · Cited by 490
Distribution of mucins at the ocular surface
Gipson, I. K. (2004) · Experimental Eye Research · doi:10.1016/s0014-4835(03)00204-5 · Cited by 440
Alterations in glycosylation as biomarkers for cancer detection
Reis, C. A., Osorio, H., Silva, L., Gomes, C., & David, L. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.071035 · Cited by 432
Gubbels, J. A., Belisle, J., Onda, M., Rancourt, C., Migneault, M., Ho, M., Bera, T. K., Connor, J., Sathyanarayana, B. K., Lee, B., et al. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-50 · Cited by 422
Dekker, J., Rossen, J. W. A., Büller, H. A., & Einerhand, A. W. C. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)02052-7 · Cited by 385
Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer
Zhang, M., Cheng, S., Jin, Y., Zhao, Y., & Wang, Y. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188503 · Cited by 384
Mucin Gene Expression in Immortalized Human Corneal–Limbal and Conjunctival Epithelial Cell Lines
Gipson, I. K., Spurr-Michaud, S., Argu¨eso, P., Tisdale, A., Ng, T. F., & Russo, C. L. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0851 · Cited by 345
Glycans and glycoproteins as specific biomarkers for cancer
Kailemia, M. J., Park, D., & Lebrilla, C. B. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9880-6 · Cited by 341
Mesothelin targeted cancer immunotherapy
Hassan, R., & Ho, M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.08.028 · Cited by 340
Gene Expression Patterns in Ovarian Carcinomas
Schaner, M. E., Ross, D. T., Ciaravino, G., Sørlie, T., Troyanskaya, O., Diehn, M., Wang, Y. C., Duran, G. E., Sikic, T. L., Caldeira, S., et al. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-05-0279 · Cited by 327
Role of Mucins in the Function of the Corneal and Conjunctival Epithelia
Gipson, I. K., & Argüeso, P. (2003) · International Review of Cytology · doi:10.1016/s0074-7696(03)31001-0 · Cited by 322
Wahrenbrock, M., Borsig, L., Le, D., Varki, N., & Varki, A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318882 · Cited by 317
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use
DUFFY, M. J., BONFRER, J. M., KULPA, J., RUSTIN, G. J. S., SOLETORMOS, G., TORRE, G. C., TUXEN, M. K., & ZWIRNER, M. (2005) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2005.00130.x · Cited by 317
Andrianifahanana, M., Moniaux, N., & Batra, S. K. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.01.002 · Cited by 314
Epithelial Ovarian Cancer: A Review of Current Management
Guppy, A. E., Nathan, P. D., & Rustin, G. J. S. (2005) · Clinical Oncology · doi:10.1016/j.clon.2005.05.009 · Cited by 311
The CA 125 Gene: An Extracellular Superstructure Dominated by Repeat Sequences
O’Brien, T. J., Beard, J. B., Underwood, L. J., Dennis, R. A., Santin, A. D., & York, L. (2001) · Tumor Biology · doi:10.1159/000050638 · Cited by 300
Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing Therapy
Romero, I., & Bast, R. C. (2012) · Endocrinology · doi:10.1210/en.2011-2123 · Cited by 286
Song, K. S., Lee, W.-J., Chung, K. C., Koo, J. S., Yang, E. J., Choi, J. Y., & Yoon, J.-H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300096200 · Cited by 281
Simple Sugars to Complex Disease—Mucin-Type O-Glycans in Cancer
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2014.11.002 · Cited by 260
Scholler, N., & Urban, N. (2007) · Biomarkers in Medicine · doi:10.2217/17520363.1.4.513 · Cited by 220
Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature
Gupta, D., & Lis, C. G. (2009) · Journal of Ovarian Research · doi:10.1186/1757-2215-2-13 · Cited by 208
Dhanisha, S. S., Guruvayoorappan, C., Drishya, S., & Abeesh, P. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.12.006 · Cited by 194
The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas
Han, L., Dong, Z., Qiao, Y., Kristensen, G. B., Holm, R., Nesland, J. M., & Suo, Z. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.06.036 · Cited by 68
Targeted delivery of platinum-taxane combination therapy in ovarian cancer
Desale, S. S., Soni, K. S., Romanova, S., Cohen, S. M., & Bronich, T. K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.007 · Cited by 61
Glycoforms of CA125 antigen as a possible cancer marker
Jankovic, M. M., & Milutinovic, B. S. (2008) · Cancer Biomarkers · doi:10.3233/cbm-2008-4104 · Cited by 59
Akita, K., Yoshida, S., Ikehara, Y., Shirakawa, S., Toda, M., Inoue, M., Kitawaki, J., Nakanishi, H., Narimatsu, H., & Nakada, H. (2012) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e3182473292 · Cited by 54
“Molecular cloning of CA125 antigen revealed that it was encoded by theMUC16 gene and was a type I membrane glycoprotein comprising a long extracellular domain, a transmembrane domain, and a short cytoplasmic domain.(2,3) The extracellular domain of MUC16 is highly modified with a variety of N- and O-glycans,(4) which…”
BackgroundLyons, J. J., Stotz, S. C., Chovanec, J., Liu, Y., Lewis, K. L., Nelson, C., DiMaggio, T., Jones, N., Stone, K. D., Sung, H., et al. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.136 · Cited by 30
A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read Sequencing
Wang, C.-W., Weaver, S. D., Boonpattrawong, N., Schuster-Little, N., Patankar, M., & Whelan, R. J. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0327 · Cited by 12
Metadata
- Authors
- Yin, B. W. T., & Lloyd, K. O.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 276
- Issue
- 29
- Pages
- 27371-27375
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2037412915
- Cited by
- 617
- References
- 28
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.